Utah Medical Products to build blood monitoring facility in Ireland:
This article was originally published in Clinica
Utah Medical Products is to construct a manufacturing facility in Athlone, Ireland. Initial capital of $4 million will come from the company's current cash supplies and production will begin in Athlone in early 1996. The new facility will house assembly operations for blood monitoring components and Utah's electrosurgery product line. This will eliminate the need for European third-party local repair and warranty service, says Utah. Moreover, the company's largest non-Baxter OEM customer has agreed to hand over its EU customer base for blood pressure monitoring kits to Utah, once the facility is complete.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.